glp-1 obesity drug news today 2025 The FDA approved Novo Nordisk's once-daily oral Wegovy tablet on December 30, 2025, marking the first oral medication for in the United States and representing a major shift in weight-loss The next phase of the

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

Explore a thorough comparison of Semaglutide and other GLP-1 receptor agonists

Get compounded GLP-1 medication for seniors with Medicare for as low as $90.00 a month for a 4-week supply

How many people take GLP-1 medications

BOC Sciences is a custom lab chemical supplier that provides a wide range of bulk compounds for the pharmaceutical, agrochemical, and biotechnology industries.